|
Reducing blood culture contamination with the use of a needleless blood draw device (PIVO Pro): An adaptive group sequential randomized controlled trial (the PIVO trial) investigator-initiated grant from Becton, Dickinson and Company |
|
|
Comparative effectiveness of interventions to prevent bloodstream infections in central venous catheters: The IVCare adaptive platform trial (IVCare) National Health and Medical Research Council (NHMRC) Investigator grant (Award ID: 2016399) and Medical Research Future Fund (MRFF) 2023 Clinical Trials Activity grant (Award ID: 2035451) |
|
|
Reducing blood culture contamination with the use of a needleless blood draw device (PIVO Pro): An adaptive group sequential randomized controlled trial (the PIVO trial) Becton, Dickinson and Company; Herston Infectious Diseased Institute (HeIDI) |
|
|
Comparative effectiveness of Class II/III medical devices to prevent bloodstream infections in central venous access devices: The IVCare adaptive platform trial (IVCare) National Health and Medical Research Council (NHMRC) Investigator grant (Award ID: 2016399) and Medical Research Future Fund (MRFF) 2023 Clinical Trials Activity grant (Award ID: 2035451) |
|